Academic Journal

Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
المؤلفون: Tombal, B., Hussain, M., Saad, F., Fizazi, K., Shore, N., Kopyltsov, E., Bögemann, M., Mendez-Vidal, M.J., Littleton, N., Srinivasan, S., Verholen, F., Smith, M.R.
المصدر: European Urology ; volume 85, page S1585 ; ISSN 0302-2838
بيانات النشر: Elsevier BV
سنة النشر: 2024
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s0302-2838(24)01220-x
الاتاحة: http://dx.doi.org/10.1016/s0302-2838(24)01220-x
https://api.elsevier.com/content/article/PII:S030228382401220X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S030228382401220X?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/
رقم الانضمام: edsbas.B37D352C
قاعدة البيانات: BASE
الوصف
DOI:10.1016/s0302-2838(24)01220-x